Bank of America
TLX

Bank of America’s Telix Pharmaceuticals TLX Stock Holding History

Bank of America’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96K Buy
10,031
+8,423
+524% +$64.2K ﹤0.01% 5526
2025
Q4 		$12K Sell
1,608
-542
-25% -$5.22K ﹤0.01% 6128
2025
Q3 		$20.6K Buy
+2,150
New +$26.3K ﹤0.01% 7064

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Bank of America's TLX Position: Q1 2026 in Review

Bank of America increased its Telix Pharmaceuticals (TLX) stake by 524% in Q1 2026, buying an estimated $64.2K and bringing the position to 10,031 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #5526.

Bank of America first reported a position in TLX in Q3 2025 and has held it in 3 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Bank of America held 10,031 shares of Telix Pharmaceuticals worth $96K as of Q1 2026.
  • Bank of America bought 8,423 Telix Pharmaceuticals shares in Q1 2026, an estimated $64.2K.
  • Telix Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5526 holding.
  • Bank of America first reported a position in Telix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.